1. Home
  2. RPRX vs BURL Comparison

RPRX vs BURL Comparison

Compare RPRX & BURL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • BURL
  • Stock Information
  • Founded
  • RPRX 1996
  • BURL 1972
  • Country
  • RPRX United States
  • BURL United States
  • Employees
  • RPRX N/A
  • BURL N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • BURL Department/Specialty Retail Stores
  • Sector
  • RPRX Health Care
  • BURL Consumer Discretionary
  • Exchange
  • RPRX Nasdaq
  • BURL Nasdaq
  • Market Cap
  • RPRX 15.6B
  • BURL 17.7B
  • IPO Year
  • RPRX 2020
  • BURL 2013
  • Fundamental
  • Price
  • RPRX $35.87
  • BURL $286.38
  • Analyst Decision
  • RPRX Strong Buy
  • BURL Strong Buy
  • Analyst Count
  • RPRX 3
  • BURL 14
  • Target Price
  • RPRX $45.33
  • BURL $344.29
  • AVG Volume (30 Days)
  • RPRX 3.1M
  • BURL 981.3K
  • Earning Date
  • RPRX 08-06-2025
  • BURL 08-28-2025
  • Dividend Yield
  • RPRX 2.45%
  • BURL N/A
  • EPS Growth
  • RPRX 54.86
  • BURL 27.81
  • EPS
  • RPRX 2.32
  • BURL 8.48
  • Revenue
  • RPRX $2,305,243,000.00
  • BURL $11,007,804,000.00
  • Revenue This Year
  • RPRX $33.77
  • BURL $11.15
  • Revenue Next Year
  • RPRX $4.62
  • BURL $8.47
  • P/E Ratio
  • RPRX $15.45
  • BURL $34.02
  • Revenue Growth
  • RPRX 3.02
  • BURL 7.60
  • 52 Week Low
  • RPRX $24.05
  • BURL $212.92
  • 52 Week High
  • RPRX $38.00
  • BURL $309.00
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 42.45
  • BURL 62.42
  • Support Level
  • RPRX $35.48
  • BURL $278.26
  • Resistance Level
  • RPRX $36.99
  • BURL $309.00
  • Average True Range (ATR)
  • RPRX 0.68
  • BURL 6.76
  • MACD
  • RPRX -0.14
  • BURL 0.30
  • Stochastic Oscillator
  • RPRX 7.28
  • BURL 50.86

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About BURL Burlington Stores Inc.

Burlington Stores Inc is off-price retailer offering an extensive selection of in-season, fashion-focused merchandise including: women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats. Company sell a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. Company sell product in category such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby and Outerwear.

Share on Social Networks: